Anaphylaxis News

Zacky Muñoz is once again in front of the California state capitol with his third piece of legislation advocating to advance the safety of school-aged children with critical allergies.

ARS Pharma has submitted a response letter to the FDA as it seeks approval for its neffy epinephrine nasal spray, which is designed to treat type I allergic reactions such as anaphylaxis, according to a company press release.

The need for a delay in skin prick testing for food allergy following an anaphylaxis reaction might be unwarranted, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The need for a delay in skin prick testing for food allergy following an anaphylaxis reaction might be unwarranted, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

WASHINGTON — When children have anaphylaxis with breathing difficulties, drug reactions and epinephrine doses, pediatric ICU admission is likely, according to a poster presentation here.

Healio has compiled February’s most-read news in asthma and allergy.

WASHINGTON — ChatGPT provided decent quality information on current anaphylaxis guidelines, but also had errors in more than half of its sources, research here showed.

WASHINGTON — Four pooled studies noted similar pharmacodynamic performance for epinephrine delivered via nasal spray or autoinjector, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Robert Wood, MD, FAAAAI, recounted the results of the OUtMATCH study to a standing-room-only crowd at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Epinephrine formulated as nasal powder demonstrated superior stability compared with autoinjector epinephrine, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.